← Eichor
Study identifier: NCT07186023 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Mindfulness or Brain Stimulation Intervention for Late-life Adults in Taiwan Urban and Rural Areas

Condition: Late-Life Adults · Late-Life Prodromal Depression · Late-Life Depression  ·  Sponsor: National Health Research Institutes, Taiwan

PhaseNA
Planned participants124
Who can joinAll sexes, 55 Years to no upper limit
Healthy volunteersYes

About this study

This randomized controlled trial will examine the effects of mindfulness-based interventions and brain stimulation interventions on cognitive function and psychological well-being in older adults. The study will employ a comprehensive assessment approach incorporating psychological evaluations, behavioral assessments, psychophysiological measurements, and neuroimaging analyses to characterize the outcome of nonpharmaceutical interventions in improving geriatric well-being or reducing depression severity.

This description comes directly from the study's public registry record.

Talk to the study team

Ai-Ling Hsu, PhD.  ·  +886-5-6327369  ·  alhsu@nhri.edu.tw

Changwei W. Wu, PhD.  ·  +886-2-66202589  ·  sleepbrain@tmu.edu.tw

Always discuss trial participation with your own doctor first.

Locations (2)

Shuang Ho Biomedical Park, Taipei Medical UniversityNew Taipei City, TaiwanRecruiting
National Center for Geriatrics and Welfare ResearchYunlin, TaiwanNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07186023